Torrent Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last four quarters, peaking at ₹2,889 crore in the latest quarter.
Operating profit margin improved to 23.43%, indicating efficiency in managing costs.
Net profit reached ₹453 crore in the latest quarter, supporting upward earnings trajectory.

NEGATIVES

Other income turned negative in the latest quarter, adversely affecting overall profitability.
Expenses increased in the latest quarter, raising concerns about cost management.
Tax rate has shown volatility, impacting net profit predictability.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	2,491	2,591	2,660	2,732	2,745	2,859	2,889	2,809	2,959	3,178
Expenses	1,764	1,800	1,835	1,863	1,862	1,955	1,950	1,895	1,995	2,146
Operating Profit	727	791	825	869	883	904	939	914	964	1,032
Other Income	9	34	26	-33	31	24	-16	33	-18	-37
Interest	107	103	91	80	80	75	64	57	56	56
Depreciation	196	191	201	213	203	197	198	199	201	201
Profit Before Tax	433	531	559	631	631	656	661	691	665	738
Tax	146	153	173	188	182	199	208	188	167	190
Net Profit	287	378	386	443	449	457	453	503	498	548
Eps in Rs	8.48	11.18	1,139	13.10	13.27	13.51	13.37	14.88	14.71	16.19